Ibogaine

Technology

Last mentioned: 19h ago

Timeline

  1. Valuation Period

    Expected timeframe for determining the fair market value of the equity investment.

  2. Option Exercised

    PsyLabs officially triggers the put option, requiring an equity investment from PBM.

  3. Put Option Established

    Psyence BioMed and PsyLabs enter into a strategic put option agreement.

Stories mentioning Ibogaine 1

funding Neutral

Psyence BioMed Strengthens Supply Chain with Strategic PsyLabs Investment

Psyence Biomedical Ltd. (Nasdaq: PBM) has confirmed a strategic equity investment in PsyLabs following the exercise of a previously established put option. This move deepens the integration between the biopharmaceutical developer and its primary manufacturer of pharmaceutical-grade psychedelic compounds.

2 sources